Read + Share
Amedeo Smart
Independent Medical Education
Son J, Jang J, Beyett TS, Eum Y, et al. A novel HER2-selective kinase inhibitor is effective in HER2 mutant and amplified non-small cell lung cancer. Cancer Res 2022 Feb 11. pii: 0008-5472.CAN-21-2693.PMID: 35149586
Email
LinkedIn
Facebook
Twitter
Privacy Policy